- 米国企業
- Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.NVCT
時価総額
$1.1億
PER
2022年 12月31日 | 2023年 12月31日 | |
Research and development | 13 | 15 |
General and administrative | 6 | 8 |
OPERATING LOSS | -19 | -23 |
Finance income | 0 | 1 |
NET LOSS | -19 | -22 |
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS | -19 | -22 |
Earnings Per Share, Basic | -1.51 | -1.43 |
Earnings Per Share, Diluted | -1.51 | -1.43 |